


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.18%
+0.51%
-2.36%
+105.37%
IMVT
Immunovant Comm
$24.07
Strengths

Upgraded on attractively valued

Earnings are forecast to grow
Chart
$17.51 (+37.46%)
$14.84 (+62.20%)
$15.75 (+52.83%)
$28.73 (-16.22%)
IMVT has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

IMVT overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Loss widens YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
IMVT Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
IMVT Street Sentiment is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is IMVT current stock price?
What are IMVT stock strengths?
What risks are associated with IMVT stock?
When is IMVT next earnings report?
What is IMVT market cap and volume?
What is IMVT's current Stock IQ?
Should I buy IMVT stock right now?
Is IMVT a Strong Buy right now?
What does a 'Strong Buy' rating mean for IMVT?
What does a 'Strong Sell' rating mean for IMVT?
What factors influence IMVT's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-1.18%
+0.51%
-2.36%
+105.37%
IMVT
Immunovant Comm
Current Price
$24.07
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Chart
$17.51 (+37.46%)
$14.84 (+62.20%)
$15.75 (+52.83%)
$28.73 (-16.22%)
IMVT Analysts Opinion
IMVT Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Loss widens YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
IMVT Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
IMVT Street Sentiment is bullish and have positive views on the near-term outlook
IMVT has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels.
IMVT Latest Analysis
Immunovants Q2 Loss Wider Than Expected Pipeline in Focus. Immunovant posts a wider Q2 loss as R&D spending rises but progress on IMVT-1402 and batoclimab fuels its pipeline momentum.
Tue Nov 11, 2025
Immunovant Inc. (NASDAQ:IMVT) Q2 2026 Earnings Call Transcript. Immunovant Inc. (NASDAQ:IMVT) Q2 2026 Earnings Call Transcript November 10 2025 Immunovant Inc. misses on earnings expectations. Reported EPS is $-0.72851 EPS expectations were $-0.72. Operator: Thank you for standing by. Welcome to the Roivant Second Quarter 2025 Earnings Call. [Operator Instructions] Please note that today’.s conference is being recorded. I will now hand the [….]
Tue Nov 11, 2025
Immunovant GAAP EPS of -$0.73 misses by $0.01.
Mon Nov 10, 2025
Immunovant: Takeover Buzz IMVT-1402 Promise And Why Im Staying Neutral.
Fri Oct 31, 2025
Immunovant (IMVT) Soars 14.6% Ahead of Q3 Results. We recently published 10 Stocks with Outstanding Gains. 9 on Record Highs. Immunovant Inc. (NASDAQ:IMVT) is one of the best-performing stocks on Thursday. Immunovant grew by 14.64 percent on Thursday to close at $24.82 apiece as investors gobbled up its shares ahead of the results of its third quarter earnings performance in the next few [….]
Fri Oct 31, 2025
Immunovant gains amid takeover speculation.
Thu Oct 30, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
IMVT Stock trends
IMVT Stock performance
IMVT Stock analysis
IMVT investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.